Addex Therapeutics Ltd - ESG Rating & Company Profile powered by AI
This assessment of Addex Therapeutics Ltd was assembled by All Street Sevva using advanced artificial intelligence. Alternative companies in the rating industry group for Addex Therapeutics Ltd are displayed below. This SDG score for Addex Therapeutics Ltd represents its transparency towards the United Nations SDGs.
Addex Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.1; made up of an environmental score of 6.0, social score of 5.3 and governance score of 6.9.
6.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 586 | Traphaco JSC | 6.2 | High |
| 586 | Xenon Pharmaceuticals Inc | 6.2 | High |
| 623 | Addex Therapeutics Ltd | 6.1 | High |
| 623 | Achieve Life Sciences Inc | 6.1 | High |
| 623 | Anatara Lifesciences Ltd | 6.1 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Addex Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Addex Therapeutics Ltd report the average age of the workforce?
Sign up for free to unlockDoes Addex Therapeutics Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Addex Therapeutics Ltd offer flexible work?
Sign up for free to unlockDoes Addex Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Addex Therapeutics Ltd conduct supply chain audits?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Addex Therapeutics Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose water use targets?
Sign up for free to unlockDoes Addex Therapeutics Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Addex Therapeutics Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Addex Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Addex Therapeutics Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Addex Therapeutics Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Addex Therapeutics Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Addex Therapeutics Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose its waste policy?
Sign up for free to unlockDoes Addex Therapeutics Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose energy use targets?
Sign up for free to unlockDoes Addex Therapeutics Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Addex Therapeutics Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Addex Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot"Marie"Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.